CB2 Activators
Items 11 to 20 of 25 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-759633 | 174627-50-0 | sc-203438 | 10 mg | $187.00 | ||
L-759633 is a selective CB2 receptor agonist. It can enhance the functional activity of CB2 by binding to the receptor, which triggers a series of signaling events leading to CB2 activation, thus enhancing the immunomodulatory roles of CB2. | ||||||
Anandamide | 94421-68-8 | sc-396321 sc-396321A sc-396321B sc-396321C | 5 mg 25 mg 500 mg 1 g | $79.00 $215.00 $3988.00 $7660.00 | 2 | |
Anandamide, an endocannabinoid, exhibits a remarkable affinity for CB2 receptors, characterized by its ability to induce allosteric modulation. This compound engages in unique hydrophobic interactions, promoting receptor activation through conformational changes. Its dynamic binding kinetics allow for transient interactions, which can fine-tune signaling cascades. Additionally, Anandamide's lipid solubility enhances its diffusion across cellular membranes, facilitating rapid bioavailability and localized effects. | ||||||
Mead acid ethanolamide | 169232-04-6 | sc-202704 sc-202704A | 1 mg 10 mg | $87.00 $825.00 | ||
Mead acid ethanolamide interacts with CB2 receptors through distinct hydrophobic and electrostatic interactions, promoting receptor activation. Its unique structural features enable it to stabilize receptor conformations, influencing downstream signaling pathways. The compound's lipid nature enhances membrane permeability, allowing for efficient cellular uptake. Furthermore, its reaction kinetics suggest a propensity for rapid dissociation, which may modulate receptor sensitivity and signaling duration. | ||||||
SER 601 | 1048038-90-9 | sc-296379 sc-296379A | 10 mg 50 mg | $189.00 $810.00 | ||
SER 601 exhibits a unique affinity for CB2 receptors, characterized by its ability to form transient complexes that facilitate receptor conformational changes. The compound's specific steric arrangement allows for selective binding, enhancing its interaction with lipid bilayers. Its dynamic reaction kinetics indicate a balance between stability and reactivity, potentially influencing the duration of receptor engagement. Additionally, SER 601's hydrophobic characteristics contribute to its solubility in lipid-rich environments, promoting effective cellular interactions. | ||||||
Arachidonamide (20:4, n-6) | 85146-53-8 | sc-221258 sc-221258A | 10 mg 50 mg | $96.00 $370.00 | ||
Arachidonamide demonstrates a distinctive interaction with CB2 receptors, primarily through its ability to modulate receptor signaling pathways. Its structural features enable it to engage in specific hydrogen bonding and hydrophobic interactions, promoting receptor activation. The compound's rapid kinetics suggest a swift onset of action, while its affinity for lipid environments enhances membrane integration. This behavior underscores its role in influencing cellular responses through nuanced receptor dynamics. | ||||||
AM 1172 | 251908-92-6 | sc-202456 sc-202456A | 10 mg 50 mg | $200.00 $650.00 | 1 | |
AM 1172 exhibits a unique affinity for CB2 receptors, characterized by its selective binding that triggers distinct intracellular signaling cascades. The compound's structural conformation allows for effective steric interactions, facilitating receptor activation. Its lipophilic nature enhances membrane penetration, leading to rapid receptor engagement. Additionally, AM 1172's kinetic profile indicates a notable speed in receptor modulation, contributing to its dynamic influence on cellular mechanisms. | ||||||
Virodhamine hydrochloride | 443129-35-9 | sc-202853 | 5 mg | $131.00 | ||
Virodhamine hydrochloride demonstrates a selective interaction with CB2 receptors, engaging in unique allosteric modulation that alters receptor conformation. This compound's hydrophobic characteristics promote efficient integration into lipid bilayers, enhancing its bioavailability. Its reaction kinetics reveal a rapid onset of action, with a propensity for transient binding that influences downstream signaling pathways. The compound's distinct molecular interactions contribute to its nuanced effects on cellular activity. | ||||||
CB 65 | 913534-05-1 | sc-361134 sc-361134A | 10 mg 50 mg | $347.00 $969.00 | ||
CB 65 exhibits a remarkable affinity for CB2 receptors, characterized by its ability to induce conformational changes that enhance receptor signaling. Its unique structure facilitates specific hydrogen bonding and hydrophobic interactions, promoting stability within lipid environments. The compound's reaction kinetics are notable for their rapid equilibrium, allowing for swift modulation of receptor activity. Additionally, CB 65's distinct molecular interactions play a crucial role in influencing cellular responses and downstream effects. | ||||||
MDA 19 | 1048973-47-2 | sc-358804 sc-358804A | 1 mg 5 mg | $28.00 $122.00 | ||
MDA 19 demonstrates a unique interaction profile with CB2 receptors, marked by its capacity to stabilize receptor conformations through specific electrostatic interactions. This compound exhibits a distinctive binding affinity that alters the receptor's activation dynamics, leading to nuanced signaling pathways. Its kinetic behavior is characterized by a delayed onset of action, allowing for prolonged receptor engagement. Furthermore, MDA 19's lipophilicity enhances its membrane permeability, influencing its bioavailability and interaction with cellular components. | ||||||
N-Arachidonoyl-L-serine | 187224-29-9 | sc-202718 | 10 mg | $230.00 | 1 | |
N-Arachidonoyl-L-serine exhibits a remarkable ability to modulate CB2 receptor activity through selective allosteric binding, which fine-tunes receptor signaling without direct competition with endogenous ligands. This compound's unique structural features facilitate specific hydrogen bonding and hydrophobic interactions, promoting distinct conformational changes in the receptor. Its dynamic reaction kinetics suggest a rapid association and slower dissociation, enhancing its functional longevity within cellular environments. | ||||||